{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:16Z","timestamp":1786985596550,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.canep.2013.12.006","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T13:04:59Z","timestamp":1390050299000},"page":"93-99","source":"Crossref","is-referenced-by-count":26,"title":["Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: A population-based study"],"prefix":"10.1016","volume":"38","author":[{"given":"Therese M.-L.","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"M\u00e5nsson-Brahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 61","key":"10.1016\/j.canep.2013.12.006_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.canep.2013.12.006_bib0010","series-title":"Cancer incidence in Sweden 2010. Official statistics of Sweden. Statistics \u2013 health and medical care","author":"Socialstyrelsen","year":"2011"},{"issue":"9","key":"10.1016\/j.canep.2013.12.006_bib0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/93.9.678","article-title":"Recent trends in cutaneous melanoma incidence among whites in the United States","volume":"93","author":"Jemal","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canep.2013.12.006_bib0020","series-title":"GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase no. 10 [Internet]","author":"Ferlay","year":"2010"},{"issue":"5","key":"10.1016\/j.canep.2013.12.006_bib0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00008390-200110000-00001","article-title":"Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review","volume":"11","author":"Masback","year":"2001","journal-title":"Melanoma Res"},{"issue":"16","key":"10.1016\/j.canep.2013.12.006_bib0030","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.canep.2013.12.006_bib0035","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/cncr.24966","article-title":"Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis","volume":"116","author":"Xing","year":"2010","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.canep.2013.12.006_bib0040","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.canep.2013.12.006_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaad.2009.01.047","article-title":"A population-based study of cutaneous melanoma in Alberta, Canada (1993\u20132002)","volume":"62","author":"Metelitsa","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.canep.2013.12.006_bib0050","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/cncr.20602","article-title":"Invasive cutaneous malignant melanoma in Sweden, 1990\u20131999. A prospective, population-based study of survival and prognostic factors","volume":"101","author":"Lindholm","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.canep.2013.12.006_bib0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.144.4.515","article-title":"Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program","volume":"144","author":"Lachiewicz","year":"2008","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.canep.2013.12.006_bib0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"Joosse","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.canep.2013.12.006_bib0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/02841861003702528","article-title":"Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"Tryggvadottir","year":"2010","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.canep.2013.12.006_bib0070","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/biostatistics\/kxl030","article-title":"Estimating and modeling the cure fraction in population-based cancer survival analysis","volume":"8","author":"Lambert","year":"2007","journal-title":"Biostatistics"},{"issue":"9","key":"10.1016\/j.canep.2013.12.006_bib0075","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.22948","article-title":"Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry","volume":"121","author":"Lambert","year":"2007","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.canep.2013.12.006_bib0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2141.2009.08026.x","article-title":"Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973\u20132001, a population-based study","volume":"148","author":"Andersson","year":"2010","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.canep.2013.12.006_bib0085","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.ejca.2010.05.028","article-title":"Does socioeconomic status influence the prospect of cure from colon cancer \u2013 a population-based study in Sweden 1965\u20132000","volume":"46","author":"Eloranta","year":"2010","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.canep.2013.12.006_bib0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-010-0752-z","article-title":"Population-based survival-cure analysis of ER-negative breast cancer","volume":"123","author":"Huang","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.canep.2013.12.006_bib0095","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ejca.2008.11.034","article-title":"The cure of cancer: a European perspective","volume":"45","author":"Francisci","year":"2009","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.canep.2013.12.006_bib0100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.27802","article-title":"Proportion cured models applied to 23 cancer sites in Norway","volume":"132","author":"Cvancarova","year":"2013","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.canep.2013.12.006_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M","article-title":"Mixture models for cancer survival analysis: application to population-based data with covariates","volume":"18","author":"De Angelis","year":"1999","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.canep.2013.12.006_bib0110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<322::AID-IJC2>3.0.CO;2-Q","article-title":"The cure for colon cancer: results from the EUROCARE study","volume":"77","author":"Verdecchia","year":"1998","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.canep.2013.12.006_bib0115","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/sim.1774","article-title":"Cure fraction estimation from the mixture cure models for grouped survival data","volume":"23","author":"Yu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.canep.2013.12.006_bib0120","unstructured":"Nationellt kvalitetsregister f\u00f6r hudmelanom. Diagnos\u00e5r 1990\u20132008. Regionalt cancercentrum syd\u00f6st. Available from: http:\/\/www.vinkcancer.se\/Global\/Diagnoser\/hudmelanom\/rapporter\/Melanom_NatKvalReg1990-2008.pdf [accessed 28.01.13]."},{"issue":"2","key":"10.1016\/j.canep.2013.12.006_bib0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2796.2006.01677.x","article-title":"Interpreting trends in cancer patient survival","volume":"260","author":"Dickman","year":"2006","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.canep.2013.12.006_bib0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"issue":"17","key":"10.1016\/j.canep.2013.12.006_bib0135","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.ejca.2011.08.010","article-title":"Estimating expected survival probabilities for relative survival analysis \u2013 exploring the impact of including cancer patient mortality in the calculations","volume":"47","author":"Talback","year":"2011","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.canep.2013.12.006_bib0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canep.2011.09.007","article-title":"Adjusting for the proportion of cancer deaths in the general population when using relative survival: a sensitivity analysis","volume":"36","author":"Hinchliffe","year":"2012","journal-title":"Cancer Epidemiol"},{"issue":"15","key":"10.1016\/j.canep.2013.12.006_bib0145","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.canep.2013.12.006_bib0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2288-11-96","article-title":"Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models","volume":"11","author":"Andersson","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.canep.2013.12.006_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J"},{"issue":"30","key":"10.1016\/j.canep.2013.12.006_bib0160","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/sim.3064","article-title":"Flexible parametric models for relative survival, with application in coronary heart disease","volume":"26","author":"Nelson","year":"2007","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.canep.2013.12.006_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0100100101","article-title":"Flexible parametric alternatives to the Cox model, and more","volume":"1","author":"Royston","year":"2001","journal-title":"Stata J"},{"issue":"8","key":"10.1016\/j.canep.2013.12.006_bib0170","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.canep.2013.12.006_bib0175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.canep.2013.12.006_bib0180","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1470-2045(10)70274-6","article-title":"Treatment implications of the emerging molecular classification system for melanoma","volume":"12","author":"Romano","year":"2011","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.canep.2013.12.006_bib0185","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.canep.2013.12.006_bib0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.canep.2013.12.006_bib0195","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ehrm.2012.01.001","article-title":"The ends justify the mean: outcome measures for estimating the value of new cancer therapies","volume":"3","author":"Davies","year":"2012","journal-title":"Health Outcomes Res Med"},{"issue":"6","key":"10.1016\/j.canep.2013.12.006_bib0200","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/cncr.11624","article-title":"Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit","volume":"98","author":"McKinnon","year":"2003","journal-title":"Cancer"},{"issue":"5 (Suppl. 1)","key":"10.1016\/j.canep.2013.12.006_bib0205","first-page":"S78","article-title":"Melanoma survival in the United States, 1992\u20132005","volume":"65","author":"Pollack","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"10.1016\/j.canep.2013.12.006_bib0210","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2013.12.006_bib0215","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.38.0584","article-title":"Superior outcome of women with stage I\/II cutaneous melanoma: pooled analysis of four European organisation for research and treatment of cancer phase III trials","author":"Joosse","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782113001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782113001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T06:13:53Z","timestamp":1716444833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782113001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1877782113001926"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2013.12.006","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}